Figure 1
Results of the questionnaires for ovarian cancer TC, paclitaxel + carboplatin; Bev, bevacizumab.

Results of the questionnaires for ovarian cancer TC, paclitaxel + carboplatin; Bev, bevacizumab.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close